Synthroid and Respiratory depression - a phase IV clinical study of FDA data

Summary:

Respiratory depression is reported as a side effect among people who take Synthroid (levothyroxine sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lamictal, and have Pain.

The phase IV clinical study analyzes which people have Respiratory depression when taking Synthroid. It is created by eHealthMe based on reports of 237,758 people who have side effects when taking Synthroid from the FDA, and is updated regularly.

What is Synthroid?

Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 249,202 Synthroid users. Check the latest studies of Synthroid.

What is Respiratory depression?

Respiratory depression (respiration has a rate below 12 breaths) is found to be associated with 713 drugs and 838 conditions by eHealthMe. Check the latest studies of Respiratory depression.

On Aug, 11, 2026

237,758 people reported to have side effects when taking Synthroid.
Among them, 55 people (0.02%) have Respiratory depression.

Could Synthroid cause Respiratory depression?

Among these 55 people:

How long have people been on Synthroid when they have Respiratory depression? *

What is the gender of people who have Respiratory depression when taking Synthroid? *

female: 83.02 %
male: 16.98 %

What is the age of people who have Respiratory depression when taking Synthroid? *

What are other drugs people take besides Synthroid? *

What are other side effects people have besides Respiratory depression? *

Malaise (a feeling of general discomfort or uneasiness): 14 people, 25.45%
Confusional State: 13 people, 23.64%
Drowsiness: 12 people, 21.82%
Pneumonia: 11 people, 20.00%
Accidental Death: 10 people, 18.18%
Ventricular Arrhythmia (problem with the rate or rhythm of the heartbeat): 10 people, 18.18%
Electrocardiogram Qt Prolonged: 10 people, 18.18%
Antidepressant Drug Level Above Therapeutic: 10 people, 18.18%
Food Interaction: 10 people, 18.18%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 10 people, 18.18%

What are the existing conditions these people have? *

Sleep Disorder: 11 people, 20.00%
Depression: 11 people, 20.00%
Pain: 11 people, 20.00%
High Blood Pressure: 3 people, 5.45%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 5.45%
Diabetes: 3 people, 5.45%
Gastric Ulcer (stomach ulcer): 3 people, 5.45%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 5.45%
Migraine (headache): 3 people, 5.45%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Synthroid and have Respiratory depression?

- Check whether Respiratory depression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Synthroid:

Synthroid (249,202 reports)

Browse all side effects of Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Respiratory depression:

Respiratory depression (713 drugs)

Browse all the conditions that are associated with Respiratory depression:

Respiratory depression (838 conditions)

Related publications that referenced our studies

Souki F, Shettar SS, "Prolonged respiratory depression after general anesthesia in an adult with congenital rubella syndrome", A&A Case Reports, 2013 Nov .
Souki F, Shettar SS, "Prolonged respiratory depression after general anesthesia in an adult with congenital rubella syndrome", A&A Case Reports, 2013 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Synthroid) and Synthroid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.